Laureate Education, Inc., together with its subsidiaries, offers higher education programs and services to students through a portfolio of higher education institutions in Mexico, Peru, and the United States.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.75, read 2026-10-25
Ethical passes the values gate
Price38.96 USD
Fair value44.80
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Accumulation38.00+2.5% to today ✓Markdown gives way to Accumulation
2026-09-04Read Markdown38.36+1.6% to today Markup gives way to Markdown with volume flow in agreement
2026-07-02Read Markup36.76+6.0% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Laureate Education, Inc. holds its Accumulation at $38.96. The statistical read favours the sellers, held for 106 days.
As held on the ledger · 2026-10-20
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 106 days
Price at the screen
$38.96
Valuation
17.71 trailing · 16.03 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.47
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
23.36%
Below 33%
Interest-bearing debt is just 23.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
17.71%
Below 49%
Money owed to the company is 17.7% of assets, under the 49% limit.
Pass
Revenue purity
0.42%
Below 5%
Only 0.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Laureate Education, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 23%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-25. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LAUR's ethical verdict changes
Today LAUR passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-20 screen. The gold marker is the market price at the same screen. A 15.0% margin of safety to the base estimate.
Third-party analyst targets: 7 covering, consensus Buy. The average target sits +5% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-20 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Education provider growing fast but lacks clear edge
Think of a student in Lima or Mexico City signing up for a degree that could lift their earnings for life. Laureate runs those institutions across three countries and is seeing revenue climb 15 percent while posting a 16 percent profit margin and 29 percent return on equity. At 14.7 times forward earnings the shares sit below our $43 fair value with an 18 percent margin of safety, yet the opportunity rating stays at none because the moat is unknown.
The business clears our ethical screen without flags, and six analysts point to a $40 median target. Numbers look steady for a defensive education name, but the absence of a visible competitive barrier keeps us from getting excited even when growth and cash returns appear solid.
Risks centre on regulatory shifts in Mexico and Peru plus currency swings that can hit reported results quickly. Unknown moat means any edge could erode faster than the numbers suggest. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
LAUR trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Accumulation$38.96+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$38.96+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$38.96+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$38.96+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$38.96-1.3%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40.
2026-10-14Accumulation$39.47+3.9%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40.
2026-09-04Markdown · changed$38.36+0.1%Entry 5
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40.
2026-08-04Markup$38.31+4.2%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40.
2026-07-18Markup$36.76+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
